NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections

Not Yet RecruitingNA

Sponsor: David Moss

Conditions: COVID-19 Respiratory Infection, Influenza

Interventions: RD-X19, RD-X19 Sham

The purpose of trial is to determine if daily usage of a photobiomodulation device will decrease the incidence of upper respiratory tract infections (URI) due to COVID, influenza or other viruses.The RD-X10 device is handheld, can be self-administered, and has been shown to be safe in invivo studies.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Active Duty and DoD Beneficiaries (i.e. former military, spouse, dependent child) aged 18 years and older who work in the Mike O'Callaghan Military Medical Center at Nellis Air Force Base.

Exclusion Criteria:

* Unable to comfortably insert RD-X19 into the mouth and keep in place for 5 minutes
* Plans for head, neck or mouth surgery during the study period
* Plans for major dental procedures (ie implants, wisdom teeth extraction etc) during the study